Messenger RNA Therapy for Female Reproductive Health-Reference-Cited by-同舟云学术

Messenger RNA Therapy for Female Reproductive Health

Published:2024-01-08 Issue:2 Volume:21 Page:393-409
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

VanKeulen-Miller Rachel¹,Fenton Owen S.²^ORCID

Affiliation:

1. Department of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

2. Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

Funder

U.S. Department of Health and Human Services

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.3c00803

Reference178 articles.

1. Gender Disparity in the Funding of Diseases by the U.S. National Institutes of Health

2. Disparities in the allocation of research funding to gynecologic cancers by Funding to Lethality scores

3. Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery

4. Regulation of protein synthesis by mRNA structure

5. RNA therapy: rich history, various applications and unlimited future prospects

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flow cytometric analysis of the murine placenta to evaluate nanoparticle platforms during pregnancy;Placenta;2024-08

2. A Lung-Expressing mRNA Delivery Platform with Tunable Activity in Hypoxic Environments;Journal of the American Chemical Society;2024-06-14

3. Polyphenolic Nanoparticle Platforms (PARCELs) for In Vitro and In Vivo mRNA Delivery;Nano Letters;2024-05-10